BTZO Financials 07/16/2014 07:54:29 Bitzio, Inc. Period

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
BTZO Financials 07/16/2014 07:54:29
Bitzio, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6 - 155 -
Cost of Revenue - - - -
Gross Profit 6 - 155 -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,002 5,673 8,083 38
Non-Recurring Items - 3,176 2,350 -
Other - - - -
Operating Income (996) (8,849) (10,279) (38)
Income From Continuing Operations
Add'l Income/Expense Items (1,073) 603 (1) -
Earnings Before Interest and Tax (2,070) (8,246) (10,280) (38)
Interest Expense 954 611 25 1
Earnings Before Tax (3,023) (8,856) (10,305) (38)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,023) (8,856) (10,305) (38)
Non Recurring Events
Discontinued Operations 313 (1,317) 425 -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,710) (10,174) (9,880) (38)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,710) (10,174) (9,880) (38)

Bitzio Inc (BTZO) Stock Research Links

BTZO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Evaluating Planet Labs' Stock Surge: Is It Still Worth Buying?

Updated Category News Views 92

Planet Labs Stock Soars: A Close Look The stock has experienced remarkable growth this year, surging by 340% year-to-date. An impressive 37% increase occurred in just one day, showcasing investor enthusiasm following a strong earnings report. Planet Labs was trading at around $3.97 per share at the start of 2025. Fast forward almost a year, and the stock has climbed to...

Continue Reading
Capricor Therapeutics: Important Class Action Details to Know

Updated Category News Views 188

Understanding the Class Action Lawsuit Against Capricor Therapeutics It is crucial for investors of Capricor Therapeutics, Inc. to stay updated regarding the ongoing class action lawsuit. If you have invested in the company's securities within the established timeframe, you may have a valid claim to pursue compensation. Key Dates and Deadlines Investors who purchased...

Continue Reading
Unforgettable Wines from Friuli Venezia Giulia Showcase

Updated Category News Views 136

Experience the Wines of Friuli Venezia Giulia in New York An incredible showcase awaits wine lovers as the Wines of Friuli Venezia Giulia make a spectacular debut on the vibrant streets of New York City. This immersive tasting experience brings together the renowned wine producers from one of Italy's most influential wine regions, allowing guests to appreciate the unique...

Continue Reading
Why Energy Fuels ($UUUU) Is a Stellar Long-Term Bet

Updated Category News Views 166

Let’s Talk Energy Fuels and Its Decade-Long Ride Alright, folks, grab a cup of coffee and buckle up because we’re diving into Energy Fuels (AMEX:UUUU) like a hawk diving on a field mouse. This is the kind of stock that if you’d thrown down a grand ten years ago, it’d be worth a jaw-dropping $8,394.74 now—yeah, you heard me right! It’s been producing an average...

Continue Reading
Purpose Investments Inc. Reveals Monthly Distributions for ETFs

Updated Category News Views 72

Monthly Distribution Announcement by Purpose Investments PURPOSE INVESTMENTS INC. is excited to share the distributions scheduled for October across its open-end exchange traded funds and closed-end funds. The upcoming disbursements aim to provide transparency to investors and stakeholders, informing them about the financial performance and expected returns of the Funds....

Continue Reading